CClinicalTrials.gg
TerminatedNCT00713596Updated Apr 18, 2016Results posted

Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty

An interventional study of Fibrinogen and Septorhinoplasty in Recovery Time and Bruising, sponsored by Mayo Clinic. Terminated at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-04-18.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment

Why this study was terminated
Lead investigator moved to a new medical center; study was stopped when he left.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether the use of fibrin glue during nasal surgery leads to a shorter recovery period with less bruising and/or swelling.

Read the detailed description

Septorhinoplasty is a well established technique to correct nasal deformity. Drawbacks of this procedure include a significant recovery following surgery which may often require nasal taping and casting. Swelling and bruising in and around the surgical site may persist for months after the operation. At present, there is no standard regarding the length of time nasal tape and cast should be used following septorhinoplasty. It has never been proven that taping or casting is required - in surgeries that require minimal amounts of tissue handling, we may not use any tape or cast following the procedure. Homologous fibrin glue has been used for various cosmetic facial plastic procedures since the early 1980's. It has been shown to decrease bruising and swelling following surgery. This study is being undertaken to evaluate these benefits of using fibrin glue in nasal surgery.

02

Conditions studied

  • Recovery Time
  • Bruising

Browse trials for

Keywords

  • Nasal Surgery
  • Septorhinoplasty
  • fibrin glue
  • fibrinogen
  • Swelling
  • fibrin
  • tisseel
03

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Any patient over 18 years of age undergoing septorhinoplasty.

Exclusion criteria

Exclusion Criteria:

  • Any patient having more than one procedure performed during one anesthetic.(i.e.brow lift, face lift, blepharoplasty)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
25 participants (actual)

Study arms

  • Sham comparator
    Control group

    Septorhinoplasty with postoperative application of nasal taping and an external nasal cast. The tape and cast will be left in place for one week. No tissue glue will be used during the operation, although the nurse and surgical assistant will simulate the preparation and insertion of tissue glue using a syringe containing saline.

    Procedure: Septorhinoplasty · Procedure: Taping after septorhinoplasty. · Procedure: Cast applied to the nose after nasal surgery · Other: Saline

  • Experimental
    Fibrinogen, tape, and cast

    Septorhinoplasty will be performed. At the termination of the procedure, prior to closure, fibrin sealant will be applied by the surgical assistant to the surgical site. Approximately 0.5 cc to 2 cc of tissue sealant will be applied. After closure, tape and cast will be applied and left in place for one week.

    Drug: Fibrinogen · Procedure: Septorhinoplasty · Procedure: Taping after septorhinoplasty. · Procedure: Cast applied to the nose after nasal surgery

  • Experimental
    Fibrinogen and tape

    Septorhinoplasty will be performed. At the termination of the procedure, prior to closure, 0.5 cc to 2 cc of tissue sealant will be applied. Nasal tape will be applied after closure.

    Drug: Fibrinogen · Procedure: Septorhinoplasty · Procedure: Taping after septorhinoplasty.

Interventions

  • DrugFibrinogen

    One time application of 0.5 cc to 2.0 cc of fibrinogen following surgery.

    Also known as: Tisseel

  • ProcedureSeptorhinoplasty

    Septorhinoplasty to correct nasal deviation.

  • ProcedureTaping after septorhinoplasty.

    Simple taping over the nose following nasal surgery.

  • ProcedureCast applied to the nose after nasal surgery

    A molded cast will be placed on top of the nose following nasal surgery.

  • OtherSaline

    Approximately 0.5 cc to 2 cc normal saline will be applied after the operation before the nasal taping and casting.

05

What researchers measure

Primary outcomes

  1. Patient Assessments of Disease-specific Quality of Life, Nasal Symptoms, and Nasal Form at 6 Months as Measured by Rhinoplasty Outcomes Evaluation (ROE), Nasal Obstructive Symptoms Evaluate Scale (NOSE), and Global Measure of Nose Deformity

    ROE: 6 items for subject's opinion re: nasal appearance, each item on 0-4 scale. Total score sum of 6 items, dividing total by 24 X 100, core ranges from 0 (least satisfied) to 100 (most satisfied). NOSE: Assess five conditions over the past month, each item on 0-4 scale X 5, then summed. Total score ranges from 0 (no problem) to 100 (severe problem). Global measure of nose deformity: Pictures of 4 indices of nasal anatomy: length, width, tip, and hump. Each index cored from 1-7, with 1=ideal nose, and 7=deformed nose. Total score = sum of 4 indices, range 4-28, lower score=more ideal nose

    Time frame: 6 months post operative

Secondary outcomes

  1. Assessment of the Results of Surgery 6 Months Post Operative by Review of Post Operative Photographs by the Operating Surgeon and 3 Blinded Reviewers Using a Mayo Clinic Surgeon Septorhinoplasty Questionnaire

    At the end of the study standard post operative rhinoplasty photos will be obtained, and the photos will be reviewed by three blinded observers, who are experienced rhinoplasty surgeons. The photos will be presented to the evaluators in a completely random fashion at a single session. These photos will be graded at that time using the same questionnaire used by the operating surgeon. The questionnaire covers bruising, swelling, tenderness, and length, width, hump and tip of nose, with a range 4-40, 4=ideal nose to 40=many postoperative problems and disfigured nose.

    Time frame: 6 months postoperative

06

Results

Posted Jul 24, 2012
Limitations and caveats
Study was terminated due to principal investigator leaving the institution.

Participant flow

Patients presenting for septorhinoplasty at the Mayo Clinic, Rochester, MN were offered the opportunity to participate in the study.

Participant flow — Overall Study
MilestoneControl GroupFibrin Sealant Group, Tape and CastFibrin Sealant Group
Started988
Completed756
Not completed232
Withdrew: Study was terminated232

Outcome measures

SecondaryAssessment of the Results of Surgery 6 Months Post Operative by Review of Post Operative Photographs by the Operating Surgeon and 3 Blinded Reviewers Using a Mayo Clinic Surgeon Septorhinoplasty Questionnaire

At the end of the study standard post operative rhinoplasty photos will be obtained, and the photos will be reviewed by three blinded observers, who are experienced rhinoplasty surgeons. The photos will be presented to the evaluators in a completely random fashion at a single session. These photos will be graded at that time using the same questionnaire used by the operating surgeon. The questionnaire covers bruising, swelling, tenderness, and length, width, hump and tip of nose, with a range 4-40, 4=ideal nose to 40=many postoperative problems and disfigured nose.

Time frame:
6 months postoperative

No measurements were reported for this outcome.

PrimaryPatient Assessments of Disease-specific Quality of Life, Nasal Symptoms, and Nasal Form at 6 Months as Measured by Rhinoplasty Outcomes Evaluation (ROE), Nasal Obstructive Symptoms Evaluate Scale (NOSE), and Global Measure of Nose Deformity

ROE: 6 items for subject's opinion re: nasal appearance, each item on 0-4 scale. Total score sum of 6 items, dividing total by 24 X 100, core ranges from 0 (least satisfied) to 100 (most satisfied). NOSE: Assess five conditions over the past month, each item on 0-4 scale X 5, then summed. Total score ranges from 0 (no problem) to 100 (severe problem). Global measure of nose deformity: Pictures of 4 indices of nasal anatomy: length, width, tip, and hump. Each index cored from 1-7, with 1=ideal nose, and 7=deformed nose. Total score = sum of 4 indices, range 4-28, lower score=more ideal nose

Time frame:
6 months post operative

No measurements were reported for this outcome.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control Group—0/9 (0%)0/9 (0%)
Fibrin Sealant Group, Tape and Cast—0/8 (0%)0/8 (0%)
Fibrin Sealant Group—0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Control GroupFibrin Sealant Group, Tape and CastFibrin Sealant GroupTotal
<=18 years0000
Between 18 and 65 years98825
>=65 years0000
Sex: Female, Male
Sex: Female, Male(Participants)Control GroupFibrin Sealant Group, Tape and CastFibrin Sealant GroupTotal
Female43310
Male55515
Region of Enrollment
Region of Enrollment(participants)Control GroupFibrin Sealant Group, Tape and CastFibrin Sealant GroupTotal
United States98825
07

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55904, United States
08

Registry details

Key details

Study ID
NCT00713596
Lead sponsor
Mayo Clinic
Responsible party
Sponsor
First posted
Jul 11, 2008
Start date
Jul 2008
Primary completion
Jan 2010
Completion
Jan 2010
Results posted
Jul 24, 2012
Last update
Apr 18, 2016

Study contacts

Oren Friedman, M.D.
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion